Insmed - Stock Price History | INSM

Historical daily share price chart and data for Insmed since 2021 adjusted for splits. The latest closing stock price for Insmed as of September 17, 2021 is 26.78.
  • The all-time high Insmed stock closing price was 195.00 on August 30, 2000.
  • The Insmed 52-week high stock price is 45.44, which is 69.7% above the current share price.
  • The Insmed 52-week low stock price is 22.00, which is 17.8% below the current share price.
  • The average Insmed stock price for the last 52 weeks is 32.83.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Insmed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 28.2231 23.6600 40.5400 13.6300 33.2900 39.41%
2019 23.3077 13.9700 32.1900 13.9100 23.8800 82.01%
2018 22.6387 32.4600 32.9900 11.6000 13.1200 -57.92%
2017 20.2914 13.0800 31.7800 11.6100 31.1800 135.68%
2016 12.7351 17.2400 17.2400 9.0500 13.2300 -27.11%
2015 20.7534 15.9600 27.5400 14.1600 18.1500 17.32%
2014 15.7364 17.1400 21.5400 11.6500 15.4700 -9.00%
2013 11.2478 6.9600 17.3300 5.7200 17.0000 154.11%
2012 4.3827 3.1500 8.0000 2.7000 6.6900 119.34%
2011 6.4065 6.4000 13.1500 2.6400 3.0500 -51.65%
2010 8.1390 7.7000 12.5000 5.7000 6.3080 -18.08%
2009 9.7689 4.9000 24.7000 4.1500 7.7000 64.71%
2008 6.0865 8.3000 9.1000 3.4990 4.6750 -43.33%
2007 8.8034 9.0000 15.6000 5.7700 8.2500 -6.25%
2006 16.1210 21.3000 31.2000 8.5000 8.8000 -55.33%
2005 12.6992 23.0000 23.0000 8.2000 19.7000 -10.41%
2004 23.1546 30.3000 40.9000 10.1000 21.9900 -25.96%
2003 20.0198 4.8000 34.2000 4.1000 29.7000 561.47%
2002 17.7447 39.4000 39.4000 3.5000 4.4900 -88.25%
2001 45.0069 37.5000 89.9000 24.7000 38.2000 10.12%
2000 120.0576 164.8000 195.0000 26.8800 34.6900 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.086B $0.164B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $173.588B 53.62
Bristol Myers Squibb (BMY) United States $136.238B 9.07
Amgen (AMGN) United States $124.575B 13.49
CSL (CSLLY) Australia $102.379B 0.00
Gilead Sciences (GILD) United States $89.785B 8.68
BioNTech SE (BNTX) Germany $87.107B 18.80
Regeneron Pharmaceuticals (REGN) United States $69.722B 11.97
Illumina (ILMN) United States $65.576B 74.50
Vertex Pharmaceuticals (VRTX) United States $48.850B 18.98
Biogen (BIIB) United States $44.738B 12.28
BeiGene (BGNE) Cayman Islands $37.507B 0.00
Seagen (SGEN) United States $28.420B 47.92
Genmab (GMAB) Denmark $28.322B 69.55
Genmab (GNMSF) Denmark $27.553B 68.87
Horizon Therapeutics Public (HZNP) Ireland $24.783B 23.49
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.621B 0.00
Bio-Techne Corp (TECH) United States $20.882B 93.91
Exact Sciences (EXAS) United States $18.596B 0.00
Novavax (NVAX) United States $17.693B 0.00
ARGENX SE-ADR (ARGX) Netherlands $17.061B 0.00
Repligen (RGEN) United States $16.850B 128.41
Incyte (INCY) United States $16.781B 39.78
BioMarin Pharmaceutical (BMRN) United States $14.257B 102.32
Guardant Health (GH) United States $13.376B 0.00
QIAGEN (QGEN) Netherlands $12.389B 20.98
Zai Lab (ZLAB) China $12.273B 0.00
Intellia Therapeutics (NTLA) United States $11.559B 0.00
CureVac (CVAC) Germany $10.301B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.489B 24.37
Ascendis Pharma (ASND) Denmark $9.109B 0.00
Mirati Therapeutics (MRTX) United States $8.985B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.829B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Acceleron Pharma (XLRN) United States $8.380B 0.00
Vir Biotechnology (VIR) United States $7.124B 0.00
Sarepta Therapeutics (SRPT) United States $6.897B 0.00
Beam Therapeutics (BEAM) United States $6.828B 0.00
Fate Therapeutics (FATE) United States $6.815B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.666B 0.00
Exelixis (EXEL) United States $6.528B 71.45
Denali Therapeutics (DNLI) United States $6.426B 182.17
Legend Biotech (LEGN) United States $6.343B 0.00
Blueprint Medicines (BPMC) United States $6.209B 17.52
Twist Bioscience (TWST) United States $6.001B 0.00
Halozyme Therapeutics (HALO) United States $5.984B 24.44
NeoGenomics (NEO) United States $5.942B 805.33
I-Mab (IMAB) China $5.838B 0.00
AbCellera Biologics (ABCL) $5.674B 0.00
Adaptive Biotechnologies (ADPT) United States $5.595B 0.00
Certara (CERT) United States $5.464B 0.00
Alkermes (ALKS) Ireland $4.858B 143.38
Arvinas (ARVN) United States $4.746B 0.00
Editas Medicine (EDIT) United States $4.314B 0.00
Reata Pharmaceuticals (RETA) United States $4.000B 0.00
Arena Pharmaceuticals (ARNA) United States $3.729B 0.00
SpringWorks Therapeutics (SWTX) United States $3.675B 0.00
Galapagos (GLPG) Belgium $3.646B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.484B 0.00
Prothena (PRTA) Ireland $3.405B 0.00
Kymera Therapeutics (KYMR) United States $3.213B 0.00
ALX Oncology Holdings (ALXO) United States $3.139B 0.00
Emergent Biosolutions (EBS) United States $3.068B 7.40
Apellis Pharmaceuticals (APLS) United States $2.976B 0.00
Amicus Therapeutics (FOLD) United States $2.932B 0.00
Cytokinetics (CYTK) United States $2.830B 0.00
Intra-Cellular Therapies (ITCI) United States $2.795B 0.00
Heska (HSKA) United States $2.777B 532.37
ACADIA Pharmaceuticals (ACAD) United States $2.683B 0.00
Myriad Genetics (MYGN) United States $2.632B 0.00
Arcus Biosciences (RCUS) United States $2.598B 0.00
Instil Bio (TIL) United States $2.544B 0.00
Celldex Therapeutics (CLDX) United States $2.528B 0.00
Morphic Holding (MORF) United States $2.460B 0.00
Sorrento Therapeutics (SRNE) United States $2.459B 0.00
C4 Therapeutics (CCCC) United States $2.420B 0.00
Ligand Pharmaceuticals (LGND) United States $2.414B 35.30
Vericel (VCEL) United States $2.410B 287.17
Seer (SEER) $2.288B 0.00
Atea Pharmaceuticals (AVIR) United States $2.171B 0.00
Alector (ALEC) United States $2.168B 0.00
Myovant Sciences (MYOV) United Kingdom $2.102B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.097B 35.72
Amarin (AMRN) Ireland $2.036B 515.00
Revance Therapeutics (RVNC) United States $2.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.988B 0.00
Castle Biosciences (CSTL) United States $1.946B 0.00
REGENXBIO (RGNX) United States $1.919B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.914B 0.00
Berkeley Lights (BLI) United States $1.819B 0.00
NGM Biopharmaceuticals (NGM) United States $1.781B 0.00
Global Blood Therapeutics (GBT) United States $1.749B 0.00
Inovio Pharmaceuticals (INO) United States $1.712B 0.00
Dynavax Technologies (DVAX) United States $1.709B 0.00
PHARMA MAR SA (PHMMF) Spain $1.699B 0.00
UniQure (QURE) Netherlands $1.696B 5.77
Dicerna Pharmaceuticals (DRNA) United States $1.680B 0.00
Zymeworks (ZYME) Canada $1.654B 0.00
Codexis (CDXS) United States $1.654B 0.00
MorphoSys AG (MOR) Germany $1.643B 0.00
Nurix Therapeutics (NRIX) United States $1.599B 0.00
Ocugen (OCGN) United States $1.576B 0.00
Bionano Genomics (BNGO) United States $1.552B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.536B 0.00
Kadmon Holdings (KDMN) United States $1.505B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.478B 0.00
Genetron Holdings (GTH) China $1.463B 0.00
MaxCyte (MXCT) United States $1.442B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.434B 0.00
PureTech Health (PRTC) United States $1.413B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.408B 0.00
Inhibrx (INBX) United States $1.403B 0.00
Scholar Rock Holding (SRRK) United States $1.396B 0.00
Sangamo Therapeutics (SGMO) United States $1.388B 0.00
Zealand Pharma (ZEAL) Denmark $1.381B 0.00
Travere Therapeutics (TVTX) United States $1.367B 0.00
Agenus (AGEN) United States $1.359B 0.00
Coherus BioSciences (CHRS) United States $1.343B 0.00
Avid Bioservices (CDMO) United States $1.287B 262.25
Fulcrum Therapeutics (FULC) United States $1.242B 0.00
Bluebird Bio (BLUE) United States $1.238B 0.00
Repare Therapeutics (RPTX) Canada $1.169B 0.00
BioAtla (BCAB) United States $1.168B 0.00
RAPT THERAPTICS (RAPT) United States $1.164B 0.00
Precigen (PGEN) United States $1.132B 0.00
MannKind (MNKD) United States $1.131B 0.00
Northwest Biotherapeutics (NWBO) United States $1.129B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.124B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.114B 0.00
ImmunityBio (IBRX) United States $1.113B 0.00
Absci (ABSI) United States $1.108B 0.00
IDEAYA Biosciences (IDYA) United States $1.032B 0.00
Nkarta (NKTX) United States $1.030B 0.00
Prometheus Biosciences (RXDX) United States $1.016B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Merus (MRUS) Netherlands $0.986B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.963B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.943B 29.22
Immatics (IMTX) Germany $0.921B 0.00
Sutro Biopharma (STRO) United States $0.908B 0.00
Avidity Biosciences (RNA) United States $0.903B 0.00
BeyondSpring (BYSI) United States $0.896B 0.00
VBI Vaccines (VBIV) United States $0.847B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.843B 0.00
Protagonist Therapeutics (PTGX) United States $0.834B 0.00
Mesoblast (MESO) Australia $0.800B 0.00
Shattuck Labs (STTK) United States $0.799B 0.00
Akoya Biosciences (AKYA) United States $0.780B 0.00
Curis (CRIS) United States $0.777B 0.00
Precision BioSciences (DTIL) United States $0.766B 0.00
Cara Therapeutics (CARA) United States $0.764B 95.31
Amryt Pharma (AMYT) United Kingdom $0.760B 0.00
AnaptysBio (ANAB) United States $0.739B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.734B 0.00
Keros Therapeutics (KROS) United States $0.717B 0.00
Mersana Therapeutics (MRSN) United States $0.710B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.702B 12.79
MiMedx (MDXG) United States $0.688B 0.00
Adagene (ADAG) China $0.663B 0.00
G1 THERAPEUTICS (GTHX) United States $0.659B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.657B 0.00
Cellectis S.A (CLLS) France $0.656B 0.00
Pliant Therapeutics (PLRX) United States $0.656B 0.00
Seres Therapeutics (MCRB) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Innate Pharma S.A (IPHA) France $0.641B 0.00
Affimed (AFMD) Germany $0.628B 0.00
Pharming Group (PHAR) Netherlands $0.627B 0.00
Spero Therapeutics (SPRO) United States $0.616B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
MeiraGTx Holdings (MGTX) United States $0.599B 0.00
ALBIREO PHARMA (ALBO) United States $0.593B 0.00
Epizyme (EPZM) United States $0.586B 0.00
Ambrx Biopharma (AMAM) United States $0.580B 0.00
VistaGen Therapeutics (VTGN) United States $0.575B 0.00
Clovis Oncology (CLVS) United States $0.573B 0.00
Anika Therapeutics (ANIK) United States $0.572B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.572B 0.00
Bolt Biotherapeutics (BOLT) United States $0.569B 0.00
Gritstone Bio (GRTS) United States $0.569B 0.00
DBV Technologies S.A (DBVT) France $0.562B 0.00
Vaccitech (VACC) United Kingdom $0.549B 0.00
Inventiva S.A (IVA) France $0.537B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.529B 0.00
Selecta Biosciences (SELB) United States $0.512B 0.00
AC Immune SA (ACIU) Switzerland $0.508B 0.00
Verastem (VSTM) United States $0.499B 0.00
Clene (CLNN) United States $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
XBiotech (XBIT) United States $0.488B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.487B 0.00
Bellus Health (BLU) Canada $0.472B 0.00
ChromaDex (CDXC) United States $0.462B 0.00
Compugen (CGEN) Israel $0.459B 0.00
Geron (GERN) United States $0.452B 0.00
Arbutus Biopharma (ABUS) United States $0.431B 0.00
Codiak BioSciences (CDAK) United States $0.427B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.425B 0.00
Oncobiologics (OTLK) United States $0.423B 0.00
Starpharma Holdings (SPHRY) Australia $0.412B 0.00
Cue Biopharma (CUE) United States $0.407B 0.00
SQZ Biotechnologies (SQZ) United States $0.406B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.406B 0.00
Clearside Biomedical (CLSD) United States $0.403B 0.00
BioDelivery Sciences (BDSI) United States $0.393B 12.09
ZIOPHARM Oncology Inc (ZIOP) United States $0.392B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.390B 0.00
Athenex (ATNX) United States $0.383B 0.00
ANI Pharmaceuticals (ANIP) United States $0.369B 10.07
Aeglea BioTherapeutics (AGLE) United States $0.367B 0.00
Cogent Biosciences (COGT) United States $0.358B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.354B 0.00
Neoleukin Therapeutics (NLTX) United States $0.350B 0.00
Theratechnologies (THTX) Canada $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.341B 0.00
Fortress Biotech (FBIO) United States $0.339B 0.00
Prima BioMed (IMMP) Australia $0.334B 0.00
Opthea (OPT) Australia $0.333B 0.00
Athersys (ATHX) United States $0.333B 0.00
INmune Bio (INMB) United States $0.327B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.318B 0.00
Syros Pharmaceuticals (SYRS) United States $0.315B 0.00
Angion Biomedica (ANGN) United States $0.313B 0.00
AquaBounty Technologies (AQB) United States $0.313B 0.00
XOMA (XOMA) United States $0.290B 122.19
WAVE Life Sciences (WVE) Singapore $0.288B 0.00
Puma Biotechnology (PBYI) United States $0.281B 0.00
Beyond Air (XAIR) United States $0.278B 0.00
Checkpoint Therapeutics (CKPT) United States $0.278B 0.00
Cardiff Oncology (CRDF) United States $0.271B 0.00
Kaleido Biosciences (KLDO) $0.248B 0.00
Frequency Therapeutics (FREQ) United States $0.247B 0.00
Kamada (KMDA) Israel $0.239B 19.89
AVEO Pharmaceuticals (AVEO) United States $0.237B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.234B 0.00
Adicet Bio (ACET) United States $0.229B 0.00
OVID THERAPEUTC (OVID) United States $0.229B 2.01
Adverum Biotechnologies (ADVM) United States $0.227B 0.00
Trevena (TRVN) United States $0.224B 0.00
Seelos Therapeutics (SEEL) United States $0.205B 0.00
Kala Pharmaceuticals (KALA) United States $0.203B 0.00
TELA Bio (TELA) United States $0.197B 0.00
NextCure (NXTC) United States $0.193B 0.00
ObsEva SA (OBSV) Switzerland $0.192B 0.00
Talis Biomedical (TLIS) United States $0.185B 0.00
OSMOTICA PHARM (OSMT) United States $0.180B 0.00
SESEN BIO, INC (SESN) United States $0.178B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.177B 0.00
HOOKIPA Pharma (HOOK) United States $0.176B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71
ATyr Pharma (LIFE) United States $0.174B 0.00
Synlogic (SYBX) United States $0.172B 0.00
ADMA Biologics Inc (ADMA) United States $0.171B 0.00
Aptinyx (APTX) United States $0.168B 0.00
Galena Biopharma (SLS) United States $0.167B 0.00
Erytech Pharma SA (ERYP) France $0.164B 0.00
Catalyst Biosciences (CBIO) United States $0.162B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Leap Therapeutics (LPTX) United States $0.158B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.157B 0.00
Biofrontera AG (BFRA) Germany $0.156B 0.00
Dyadic (DYAI) United States $0.151B 0.00
LogicBio Therapeutics (LOGC) United States $0.150B 0.00
TScan Therapeutics (TCRX) United States $0.150B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.147B 0.00
Applied Genetic Technologies (AGTC) United States $0.147B 0.00
Vascular Biogenics (VBLT) Israel $0.145B 0.00
Strongbridge Biopharma (SBBP) United States $0.144B 0.00
Nicox SA (NICXF) France $0.142B 0.00
Novogen (KZIA) Australia $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Cyclerion Therapeutics (CYCN) United States $0.135B 0.00
X4 Pharmaceuticals (XFOR) United States $0.131B 0.00
Evofem Biosciences (EVFM) United States $0.130B 0.00
Purple Biotech (PPBT) Israel $0.128B 0.00
Eton Pharmaceuticals (ETON) United States $0.126B 0.00
Orgenesis (ORGS) United States $0.125B 0.00
Exicure (XCUR) United States $0.124B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.122B 0.00
Abeona Therapeutics (ABEO) United States $0.121B 0.00
Voyager Therapeutics (VYGR) United States $0.118B 6.76
Eyenovia (EYEN) United States $0.117B 0.00
Entera Bio (ENTX) Israel $0.114B 0.00
Yumanity Therapeutics (YMTX) United States $0.114B 0.00
Viridian Therapeutics (VRDN) United States $0.112B 0.00
Cidara Therapeutics (CDTX) United States $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.102B 0.00
Pluristem Therapeutics (PSTI) Israel $0.096B 0.00
Aadi Bioscience (AADI) United States $0.093B 0.00
Celsion (CLSN) United States $0.092B 0.00
Emmaus Life Sciences (EMMA) United States $0.085B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Zosano Pharma (ZSAN) United States $0.084B 0.00
ARAVIVE, INC (ARAV) United States $0.084B 0.00
Lumos Pharma (LUMO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
Statera Biopharma (STAB) United States $0.082B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.081B 0.00
Liminal BioSciences (LMNL) Canada $0.081B 0.00
Aytu BioPharma (AYTU) United States $0.079B 0.00
DiaMedica Therapeutics (DMAC) United States $0.079B 0.00
Evogene (EVGN) Israel $0.078B 0.00
Edesa Biotech (EDSA) Canada $0.078B 0.00
Advaxis (ADXS) United States $0.077B 0.00
AEterna Zentaris (AEZS) United States $0.076B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
ABVC BioPharma (ABVC) United States $0.070B 0.00
AIkido Pharma (AIKI) United States $0.070B 0.00
Longeveron (LGVN) United States $0.069B 0.00
Vyant Bio (VYNT) United States $0.069B 0.00
Celyad SA (CYAD) Belgium $0.068B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Enveric Biosciences (ENVB) United States $0.054B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.053B 0.00
Antibe Therapeutics (ATBPF) Canada $0.053B 0.00
Acorda Therapeutics (ACOR) United States $0.053B 1.10
BioCardia (BCDA) United States $0.052B 0.00
Genetic Technologies (GENE) Australia $0.052B 0.00
Forte Biosciences (FBRX) United States $0.051B 0.00
Windtree Therapeutics (WINT) United States $0.050B 0.00
ARIDIS PHARMACT (ARDS) United States $0.049B 0.00
Vallon Pharmaceuticals (VLON) United States $0.048B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Cyclo Therapeutics (CYTH) United States $0.044B 0.00
Soligenix (SNGX) United States $0.043B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Palisade Bio (PALI) United States $0.035B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Benitec Biopharma (BNTC) United States $0.032B 0.00
GeoVax Labs (GOVX) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
ZIVO Bioscience (ZIVO) United States $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00